Cargando…
Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Ischemia reperfusion injury (IRI) is an adverse factor for hepatocellular carcinoma (HCC) recurrence after liver transplantation. Ischemic-free liver transplantation (IFLT) is a novel transplant procedure that can largely reduce or even prevent IRI, but the clinical relevance of IFLT and the recurre...
Autores principales: | Tang, Yunhua, Wang, Tielong, Ju, Weiqiang, Li, Fangcong, Zhang, Qi, Chen, Zhitao, Gong, Jinlong, Zhao, Qiang, Wang, Dongping, Chen, Maogen, Guo, Zhiyong, He, Xiaoshun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711268/ https://www.ncbi.nlm.nih.gov/pubmed/34966679 http://dx.doi.org/10.3389/fonc.2021.773535 |
Ejemplares similares
-
A marginal liver graft with hyperbilirubinemia transplanted successfully by ischemia-free liver transplantation
por: Huang, Changjun, et al.
Publicado: (2021) -
Neoadjuvant programmed cell death 1 inhibitor before liver transplantation for HCC is not associated with increased graft loss
por: Wang, Tielong, et al.
Publicado: (2023) -
Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation
por: Chen, Zhitao, et al.
Publicado: (2020) -
Application of various surgical techniques in liver transplantation: a retrospective study
por: Chen, Zhitao, et al.
Publicado: (2021) -
An Alternative Surgical Technique of Native Hepatectomy in Liver Transplantation
por: Chen, Maogen, et al.
Publicado: (2021)